The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1445
June 23, 2014
View Complete Issue         Table of Contents 2019 
Low-Dose Aspirin for Prevention of Preeclampsia
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Low-Dose Aspirin for Prevention of Preeclampsia
June 23, 2014 (Issue: 1445)
The American College of Obstetricians and Gynecologists (ACOG) and the US Preventive Services Task Force (USPSTF) have recommended that women at risk for preeclampsia take low-dose aspirin daily after the first trimester.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Low-Dose Aspirin for Prevention of Preeclampsia
Article code: 1445a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.